CON · XBRL financial data

Concentra Group Holdings Parent financial statements, every quarter

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (CON's year ends in late December)

In millions of dollars	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	478	490	465*	501	551	573	539*	570	606
General and administrative	37	37	45*	47	53	53	51*	55	57
Other operating income (expense)	0	0	0*	0	0	0	0*	0	(0)
Operating income (loss)	84	86	59*	80	90	94	70*	96	115
Interest expense	—	—	year only	26	—	—	year only	26	—
Income tax expense (benefit)	18	16	10*	13	15	16	7*	17	22
Net income (loss)	52	44	22*	39	45	48	35*	50	65
Earnings per share, basic USD per share	0.50	0.37	0.17*	0.30	0.35	0.38	0.27*	0.39	0.51
Earnings per share, diluted USD per share	0.50	0.37	0.17*	0.30	0.35	0.38	0.27*	0.39	0.51
Weighted average shares, basic millions of shares	104	121	127*	127	127	127	126*	126	125
Weighted average shares, diluted millions of shares	104	121	127*	127	128	128	130*	128	128

Fiscal quarters (CON's year ends in late December)

In millions of dollars	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	51	137	183	52	74	50	80	62	158
Accounts receivable	229	232	218	258	272	279	258	297	300
Prepaid and other current assets	—	—	—	—	—	—	45	—	49
Total current assets	320	410	437	352	395	375	383	404	506
Property and equipment, net	187	191	—	—	—	—	—	—	—
Right-of-use asset	399	430	436	463	473	484	484	501	522
Goodwill	1,233	1,235	1,235	1,445	1,481	1,483	1,479	1,480	1,480
Total assets	2,363	2,481	2,521	2,729	2,842	2,844	2,858	2,890	3,010
Accounts payable	—	—	20	35	39	33	21	32	36
Total current liabilities	265	270	307	320	335	313	337	321	368
Lease liability, non-current	360	391	397	406	430	442	444	461	483
Total liabilities	1,093	2,180	2,222	2,398	2,474	2,434	2,438	2,436	2,504
Retained earnings	784	0	14	44	80	120	146	187	244
Total stockholders' equity	1,247	278	276	307	343	385	393	425	477
Total liabilities and equity	2,363	2,481	2,521	2,729	2,842	2,844	2,858	2,890	3,010
Common shares outstanding (cover page) millions of shares	127	127	128	128	128	128	129	128	128

Fiscal quarters (CON's year ends in late December)

In millions of dollars	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	52	44	22*	39	45	48	35*	50	65
Stock-based compensation	0*	0*	2*	2	2*	2*	4*	4	4*
Net cash from operating activities	70*	66*	94*	12	88*	61*	119*	21	135*
Purchases of property and equipment	15*	15*	17*	16	25*	21*	20*	11	16*
Net cash from investing activities	(15)*	(17)*	(17)*	(295)	(80)*	(20)*	(20)*	(15)	(14)*
Share repurchases	—	—	year only	—	—	—	year only	—	—
Dividends paid	—	0*	8*	0	16*	8	8	8	8
Net cash from financing activities	(54)*	37*	(31)*	152	13*	(64)*	(69)*	(24)	(25)*
Net change in cash	1*	86*	46*	(131)	22*	(24)*	30*	(18)	96*

SIC 8093 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8093 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Concentra Group Holdings Parent	158	606	135*	127.5M	Q2 FY26 10-QJun 30, 2026
Acadia Healthcare Company	163	895	98*	93.0M	Q3 FY26 10-QSep 30, 2026
Progyny	153	351	50*	76.7M	Q2 FY26 10-QJun 30, 2026
Sotera Health	412	325	111*	285.6M	Q3 FY26 10-QSep 30, 2026
agilon health	174	1,519	50*	16.8M	Q3 FY26 10-QSep 30, 2026
Davita	496	3,578	519*	62.9M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.